We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
+27.96%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$514M
AUM Growth
-$45.1M
Cap. Flow
-$126M
Cap. Flow %
-24.6%
Top 10 Hldgs %
70.54%
Holding
81
New
6
Increased
6
Reduced
6
Closed
9

Top Buys

1
BC icon
Brunswick
BC
+$13.7M
2
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$1.84M
3
HCARU
Healthcare Services Acquisition Corporation Unit
HCARU
+$1.54M
4
SONO icon
Sonos
SONO
+$1.21M
5
CRIS icon
Curis
CRIS
+$861K

Top Sells

1
RPRX icon
Royalty Pharma
RPRX
+$38.9M
2
XRX icon
Xerox
XRX
+$35.4M
3
DCP
DCP Midstream, LP
DCP
+$31.8M
4
AMAG
AMAG Pharmaceuticals
AMAG
+$12.2M
5
EOSE icon
Eos Energy Enterprises
EOSE
+$5M

Sector Composition

1 Healthcare 19.85%
2 Industrials 14.37%
3 Consumer Discretionary 11.57%
4 Materials 9.88%
5 Financials 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BATRA icon
51
Atlanta Braves Holdings Series A
BATRA
$3.63B
$258K 0.05%
10,356
– –
XFOR icon
52
X4 Pharmaceuticals
XFOR
$360M
$230K 0.04%
1,191
– –
CARR icon
53
Carrier Global
CARR
$57.1B
$226K 0.04%
6,000
– –
OTIS icon
54
Otis Worldwide
OTIS
$28.2B
$203K 0.04%
3,000
– –
PHYS icon
55
Sprott Physical Gold
PHYS
$14.4B
$189K 0.04%
12,540
– –
LILAK icon
56
Liberty Latin America Class C
LILAK
$1.48B
$183K 0.04%
18,174
– –
LGF.B
57
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$170K 0.03%
16,413
– –
CZOO
58
DELISTED
Cazoo Group Ltd
CZOO
$124K 0.02%
+5
New +$118K
BNY
59
Bank of New York Mellon
BNY
$108B
$85K 0.02%
2,000
– –
XLNX
60
DELISTED
Xilinx Inc
XLNX
$75K 0.01%
530
– –
CDNS icon
61
Cadence Design Systems
CDNS
$91B
$72K 0.01%
525
– –
TER icon
62
Teradyne
TER
$50.5B
$72K 0.01%
600
– –
XRX icon
63
Xerox
XRX
$362M
$72K 0.01%
3,125
-1,673,100
-100% -$35.4M
LITE icon
64
Lumentum
LITE
$57B
$63K 0.01%
660
– –
PRGX
65
DELISTED
PRGX Global, Inc.
PRGX
$61K 0.01%
7,938
– –
ABBV icon
66
AbbVie
ABBV
$450B
$55K 0.01%
515
– –
MO icon
67
Altria Group
MO
$124B
$49K 0.01%
1,200
– –
T icon
68
AT&T
T
$152B
$47K 0.01%
2,185
– –
LILA icon
69
Liberty Latin America Class A
LILA
$1.48B
$45K 0.01%
5,913
– –
XOM icon
70
ExxonMobil
XOM
$611B
$44K 0.01%
1,075
– –
ADEA icon
71
Adeia
ADEA
$2.8B
$2K ﹤0.01%
340
– –
AVNW icon
72
Aviat Networks
AVNW
$269M
$1K ﹤0.01%
66
– –
ADVM
73
DELISTED
Adverum Biotechnologies
ADVM
– –
-15,000
Closed -$1.54M
CDNA icon
74
CareDx
CDNA
$2.05B
– –
-125,000
Closed -$4.74M
EOSE icon
75
Eos Energy Enterprises
EOSE
$1.47B
– –
-500,000
Closed -$5M
1 2
3
4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q4 2020 Portfolio in Review

As of Q4 2020, Bleichroeder LP held 81 positions worth $514M, down 8.1% from $559M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bleichroeder LP withdrew a net $126M in Q4 2020, closing 9 positions and reducing 6 holdings. Its most notable exit was DCP Midstream, LP, an estimated $31.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Bleichroeder LP opened a new position in Healthcare Services Acquisition Corporation Unit worth $1.53M.

  • Bleichroeder LP's largest Q4 2020 buy was Healthcare Services Acquisition Corporation Unit: 150,000 shares worth $1.53M.
  • Bleichroeder LP added most to Brunswick in Q4 2020, an estimated $13.7M increase.
  • Bleichroeder LP's biggest Q4 2020 reduction was Royalty Pharma, cutting an estimated $38.9M.
  • Bleichroeder LP fully exited DCP Midstream, LP in Q4 2020, selling an estimated $31.8M.
  • Bleichroeder LP's ten largest holdings make up 71% of its $514M portfolio in Q4 2020.
  • Bleichroeder LP opened 6 new positions and closed 9 in Q4 2020.
  • Bleichroeder LP's portfolio value fell 8.1% quarter-over-quarter to $514M.

Based on Bleichroeder LP's 13F filing for Q4 2020, filed 10 Feb 2021.